 |
|
|
| |
Ledipasvir/Sofosbuvir With Ribavirin is Safe and Efficacious in Decompensated and Post-Liver Transplantation Patients With HCV Infection: Preliminary Results of the SOLAR-2 Trial
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Michael Manns1, Xavier Forns2, Didier Samuel3, Jill Denning4, Sarah Arterburn4, Theo Brandt-Sarif4, Hadas Dvory-Sobol4, Phillip S. Pang4, John G. McHutchison4, Edward Gane5, David Mutimer6
1Hannover Medical School, Hannover, Germany; 2Liver Unit, IDIBAPS, CIBEREHD Hospital Clinic, Barcelona, Spain; 3Université Paris-Sud, Villejuif, France; 4Gilead Sciences, Foster City, California, USA; 5University of Auckland, Auckland, New Zealand; 6Queen Elizabeth Hospital and University of Birmingham, Birmingham, England
|
| |
|
|
|
|
|
